Gosselin P, Cazin J L, Demaille M C, Sulman C
Laboratoire de Radiopharmacie et Pharmacie Clinique, Centre Oscar-Lambret, Lille.
Rev Fr Gynecol Obstet. 1988 Jul-Sep;83(7-9):535-40.
The main tumor markers used in breast and gynaecological neoplasias are reviewed with their individual characteristics: carcino-embryonic antigen (CEA), alpha-fetoprotein (AFP), chorionic gonadotropin hormone (CGH), CA 125, CA 15.3 and Squamous Cell Carcinoma Antigen (SCC). Their indications are specified according to the following cancer locations: breast, trophoblast, ovary, endometrium and cervix. The major clinical applications of the tumor markers routinely used are emphasized.
